Analyst Reco. BiomX Inc.

Equities

PHGE

US09090D1037

Market Closed - Nyse Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
0.3701 ^USD	-11.46%		-11.46%	+32.18%

May. 21	Transcript : BiomX Inc., Q1 2024 Earnings Call, May 21, 2024
May. 20	BiomX Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Cuts Price Target on BiomX to $7 From $10, Maintains Buy Rating	23-05-15	MT
Chardan Lowers Price Target on BiomX to $2 From $6, Keeps Buy Rating	22-11-10	MT
Chardan Lowers BiomX's Price Target to $6 From $10, Maintains Buy Rating	22-05-24	MT
Ladenburg Thalmann Lowers BiomX's Price Target to $8 From $13, Maintains Buy Rating	22-05-12	MT
Chardan Research Trims Price Target on BiomX to $12 From $13; Buy Rating Kept	22-03-31	MT
Chardan Research Trims Price Target on BiomX to $13 From $16; Buy Rating Kept	21-11-16	MT
BIOMX : Chardan Adjusts Price Target on BiomX to $16 From $28 After "Disappointing" Drug Trial Results, Maintains Buy Rating	21-10-19	MT
BIOMX : HC Wainwright Adjusts BiomX Price Target to $10 From $20, Maintains Buy Rating	21-10-18	MT
BIOMX : Ladenburg Thalmann Initiates BiomX at Buy With $25 Price Target	21-04-15	MT
BIOMX : HC Wainwright Starts BiomX at Buy With $20 Price Target	20-12-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer